Filtrer vos résultats
- 2
- 1
- 3
- 3
- 1
- 1
- 1
- 3
- 3
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
triés par
|
Innovative anticancer agents reserved to hospital use and not involved in the hospital budget: Creation and evolutionBulletin du Cancer, 2016, 103 (4), pp.315-317. ⟨10.1016/j.bulcan.2016.02.013⟩
Article dans une revue
hal-03598686v1
|
|||
|
TACE and conformal radiotherapy vs. TACE alone for hepatocellular carcinoma: A randomised controlled trialJHEP Reports Innovation in Hepatology, 2023, 5 (4), pp.100689. ⟨10.1016/j.jhepr.2023.100689⟩
Article dans une revue
hal-04044132v1
|
||
|
Benefit of a Flash Dose of Corticosteroids in Digestive Surgical Oncology : A Multicenter, Randomized, Double Blind, Placebo-Controlled Trial (CORTIFRENCH).BMC Cancer, 2022, 22 (1), pp. 913. ⟨10.1186/s12885-022-09998-z⟩
Article dans une revue
hal-03760909v1
|